Doctor profile · Federal record
Dr. JOHN CAREY, M.D.
Dermatology Physician (CMS: DERMATOLOGY) · Procedural Dermatology Physician · Dermatopathology (Pathology) Physician · ALBUQUERQUE, NM
- NPI 1770578924
- Accepts Medicare
- MIPS 0.0 / 100 · 2023
- 28 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
12241 ACADEMY RD NE, SUITE 204
ALBUQUERQUE, NM 871118051
(505) 938-4214
fax (505) 944-7720
Credentials & registration
- NPI registered
- September 2005 — 21 yrs on file
- Profile last updated
- May 22, 2014
- Year of graduation
- 1998 — 28 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State licenses (2)
- New Mexico #20020450 · New Mexico #MD2002-0450
- Medicaid
- NM #76659755
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1770578924. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
3,202
Distinct HCPCS
10
Medicare allowed
$157,610
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
88305 |
Pathology examination of tissue using a microscope, intermediate complexity | 1,565 | 494 | $30 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 619 | 93 | $6 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 278 | 204 | $121 | |
88309 |
Pathology examination of tissue using a microscope, high complexity | 196 | 87 | $94 | |
17000 |
Destruction of precancer skin growth, 1 growth | 131 | 115 | $44 | |
17110 |
Destruction of skin growth, 1-14 growths | 98 | 86 | $94 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 93 | 79 | $85 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 78 | 58 | $159 | |
17111 |
Destruction of skin growth, 15 or more growths | 34 | 27 | $117 | |
17261 |
Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | 26 | 15 | $101 |
In context: peer comparison
Among 12 peers in this city , average services per provider: 242. This provider delivers 13× the peer median.Open Payments
Industry payments received
All-time total
$611
Transactions
33
Manufacturers
7
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 22 | $261.00 | |
| REVANCE THERAPEUTICS, INC. | 2 | $153.04 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $75.17 | |
| Lilly USA, LLC | 2 | $37.96 | |
| Galderma Laboratories, L.P. | 2 | $32.41 | |
| Amgen Inc. | 1 | $30.87 | |
| Incyte Corporation | 1 | $20.36 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
313
Patients
120
Total drug cost
$20,157
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Clobetasol Propionate | Generic | 57 | 21 | $5,378 |
| Triamcinolone Acetonide | Generic | 51 | 26 | $727 |
| Gabapentin | Generic | 34 | 11 | $853 |
| Econazole Nitrate | Generic | 29 | 14 | $545 |
| Mupirocin | Generic | 24 | 22 | $203 |
| Ketoconazole | Generic | 18 | 0 | $328 |
| Imiquimod | Generic | 17 | 15 | $361 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 17 | 0 | $836 |
| Doxycycline Hyclate | Generic | 15 | 0 | $200 |
| Acitretin | Generic | 14 | 0 | $7,166 |